/CNW Telbec/ - The human immunodeficiency virus (HIV-1) particularly attacks CD4 lymphocytes, a type of white blood cell considered to be the conductor of the.
E-Mail
IMAGE: INRS Professor Julien van Grevenynghe, expert in immunology and virology, and doctoral student Hamza Loucif, first author of the paper. view more
Credit: INRS
Prompted by the need to improve conventional treatments for people infected with the human immunodeficiency virus (HIV-1), a team from the Institut national de la recherche scientifique (INRS) has identified a therapeutic approach to restore the effectiveness of immune cells. The study, led by doctoral student Hamza Loucif and Professor Julien van Grevenynghe, was published in the journal
Autophagy.
Most people infected with HIV-1 require daily antiretroviral therapy to control the infection. These drugs cause significant side effects without fully restoring the normal functioning of the immune system. Yet, a specific group of patients, called elite controllers , are able to live with the infection without any drug intervention.
HIV: an innovative therapeutic breakthrough to optimize the immune system — Agenparl agenparl.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from agenparl.eu Daily Mail and Mail on Sunday newspapers.